| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1942fe9954bd1871fa26f7012501ef28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ebc8b1d9f56f223119afbb7938779bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a80ff026764e5e43628b75166385c21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef5865b98b974263fb60d0bc8f129421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9833dd8f5f7128084d69a66fd65b185 |
| publicationDate |
2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022174808-A1 |
| titleOfInvention |
ANTIBODY AGAINST IL-13Rα2 AND USE THEREOF |
| abstract |
Provided are an antibody against IL-13Rα2 or antigen binding fragment thereof, a derivative and a pharmaceutical composition comprising the antibody or antigen binding fragment thereof. In addition, further provided is use of the antibody or the antigen binding fragment thereof in treatment, prevention or detection of diseases related to the IL-13Rα2 receptor. |
| priorityDate |
2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |